When Richard Lowenthal, president and CEO of ARS Pharmaceuticals, mentioned that parents were leaving the EpiPen in the car and throwing it away due to fear of it getting hot, it raised an important alarm regarding the importance of temperature testing medical supplies. This revelation is crucial as it highlights the potential dangers of not
Health
UnitedHealth Group (UHG) has emerged as a dominant force in the healthcare industry, with nearly $400 billion in revenue and $22.4 billion in profits in 2023 alone. This financial success has been achieved through vertical integration, allowing UHG to control everything from health insurance to pharmaceuticals. This level of control raises concerns about the impact
Amblyopia, commonly referred to as “lazy eye,” has been linked to an increased risk of cardiometabolic disorders in adulthood, according to a recent observational cohort study conducted by researchers at University College London’s (UCL) Great Ormond Street Institute of Child Health. The study, which involved individuals over the age of 40 living with amblyopia, revealed
A recent Phase II randomized controlled trial has shown promising results for a novel fixed-dose combination of alpibectir-ethionamide in patients with tuberculosis (TB). The trial demonstrated similar levels of bactericidal activity to isoniazid, a commonly used anti-TB drug, with no serious adverse events and good tolerability. It is essential to find new treatment options for
In a recent prospective cohort study conducted by Elan Louis, MD, and his team at the University of Texas Southwestern Medical Center in Dallas, it was found that the prevalence of dementia in individuals with essential tremor was significantly higher than that of the general population. Over a 5-year period, the cumulative prevalence of dementia
The integration of artificial intelligence (AI) into healthcare settings, specifically in clinician-patient conversations, raises serious concerns regarding security and privacy issues. While AI has the potential to streamline processes and improve patient care, the lack of clarity surrounding data protection and confidentiality is a significant barrier to its widespread adoption. The announcement of a new
The recent data from the CDC’s IVY and VISION networks have shed light on the protection provided by the newly updated COVID vaccines against severe virus-related outcomes in immunocompetent adults. According to Jennifer DeCuir, MD, PhD, and colleagues, the vaccine effectiveness (VE) against COVID-related emergency department or urgent care encounters ranged from 47% to 52%,
A recent study presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum revealed that patients with relapsing multiple sclerosis (RMS) who were continuously treated with ozanimod (Zeposia) for 7 to 8 years exhibited stable or improved clinical and radiologic measures of disease activity. Regardless of the age category, the adjusted
Obesity is a significant health concern worldwide, with numerous associated risks and complications. Recent research has highlighted a potential link between obesity and the progression of multiple sclerosis (MS). A prospective cohort study conducted by Lars Alfredsson, PhD, at the Karolinska Institute in Stockholm, Sweden, presented findings at the ACTRIMS Forum 2024, shedding light on
The effectiveness of flu shots in the current U.S. winter flu season has been estimated to be around 40% for preventing adults from getting sick enough to require medical attention, according to health officials. Children who received the flu vaccine were approximately 60% less likely to seek treatment at a doctor’s office or hospital. These